mAb Development

Aug 01, 2017
BioPharm International
Improved resin chemistries and customized separation solutions are enabling more efficient separations.
Aug 01, 2017
By BioPharm International Editors
FDA advances the progress of biosimilars with acceptance of regulatory filing for biosimilar referencing a blockbuster biologic by Roche.
Aug 01, 2017
By BioPharm International Editors
Horizon to make publicly available its complete annotated CHO cell-line sequence in hopes of driving bioproduction cell-line innovation.
Jul 01, 2017
BioPharm International
Continuous processing of 100 g of monoclonal antibody in 24 hours has been demonstrated using lab-scale equipment.
Jul 01, 2017
BioPharm International
The authors present a shift toward more integrated purification processes.
May 01, 2017
BioPharm International
The unique structures of fusion proteins lead to expression, heterogeneity, and stability issues.
Apr 01, 2017
BioPharm International
Including next-gen antibodies in pharma pipelines is considered essential for future success.
Feb 27, 2017
By BioPharm International Editors
Sanofi and Lonza formed a joint venture to build and operate a large-scale mammalian cell culture facility for monoclonal antibody production in Visp, Switzerland.
Feb 14, 2017
Evaluate and BioPharm International highlight the antibody-based therapeutics that may have 2017 launch dates in the United States.
Feb 13, 2017
EvaluatePharma and BioPharm International highlight the antibody-based therapeutics that may gain United States Regulatory approval in 2017.
native1_300x100
lorem ipsum